Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?;¿Existe asociación entre la fibromialgia, el aumento de la comorbilidad por enfermedad neoplásica, cardiovascular e infecciones, y el de la mortalidad?

Reumatologia Clinica

Volumn 1, Issue 4, 2005, Pages 200-210

  Chamizo Carmona, E ^a  

^a Unidad de Reumatología Hospital General de Mérida España   (Spain)

Author keywords

Cancer; Cardiovascular disease; Comorbidity; Fibromyalgia; Infections; Mortality; Prognosis

Indexed keywords

EID: 33645749180     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/S1699-258X(05)72745-5     Document Type: Article

References (32)

1. Neumann L., and Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 7 (2003) 362-368
2. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
3. Laupacis A., Wells G., Richardson W.S., and Tugwell P. User's guides to the medical literature. V. How to use an article about prognosis. JAMA 272 (1994) 234-237
4. Wolfe F., and Hawley D.J. Fibromyalgia in the adult Danish population. Scand J Rheumatol 23 (1994) 55-56
5. Wigers S.H. Fibromyalgia outcome: the predictive values of symptom duration, physical activity, disability pension, and critical life events-a 4.5 year prospective study. J Psychosom Res 41 (1996) 235-243
6. Croft P., Rigby A.S., Boswell R., Schollum J., and Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 20 (1993) 710-713
7. White K.P., Speechley M., Harth M., and Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26 (1999) 1570-1576
8. Forseth K.O., Forre O., and Gran J.T. A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol 18 (1999) 114-121
9. White K.P., Nielson W.R., Harth M., Ostbye T., and Speechley M. Does the label "fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 47 (2002) 260-265
10. Mengshoel A.M., and Haugen M. Health status in fibromyalgia-a followup study. J Rheumatol 28 (2001) 2085-2089
11. Aaron L.A., and Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and comorbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 17 (2003) 563-574
12. Makela M., and Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. BMJ 303 (1991) 216-219
13. Wolfe F., Anderson J., Harkness D., Bennett R.M., Caro X.J., Goldenberg D.L., et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40 (1997) 1560-1570
14. Wolfe F., and Hawley D.J. Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 17 (1999) 297-303
15. Buskila D., Neumann L., Odes L.R., Schleifer E., Depsames R., and Abu-Shakra M. The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Semin Arthritis Rheum 30 (2001) 411-417
16. Macfarlane G.J., McBeth J., and Silman A.J. Widespread body pain and mortality: prospective population based study. BMJ 323 (2001) 662-665
17. McBeth J., Silman A.J., and Macfarlane G.J. Association of widespread body pain with an increased risk of cancer and reduced cancer survival: a prospective, population-based study. Arthritis Rheum 48 (2003) 1686-1692
18. Dreyer L., Winther J.F., and Mellenkjaer L. Cancer Incidence in fibromyalgia: a Danish cohort followed for 16 year [abstract] (2004), EULAR, Berlin
19. Bernatsky S., Dobkin P.L., De Civita M., and Penrod J.R. Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 135 (2005) 76-81
20. Wolfe F., and Hawley D.J. The long time outcomes of fibromyalgia: rates and predictors of mortality in fibromyalgia after 25 years of follow-up [abstract] (1999), ACR, Boston
21. Pimentel M., Chow E.J., Hallegua D., Wallace D., and Lin H.C. Small intestinal bacterial overgrowth: a possible association with fibromyalgia. J Musculoskelet Pain 9 (2001) 107-113
22. Pimentel M., Wallace D., Hallegua D., Chow E., Kong Y., Park S., et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 63 (2004) 450-452
23. Berg A.M., Naides S.J., and Simms R.W. Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol 20 (1993) 1941-1943
24. Rea T., Russo J., Katon W., Ashley R.L., and Buchwald D. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Arch Intern Med 159 (1999) 865-870
25. Wittrup I.H., Jensen B., Bliddal H., Danneskiold-Samsoe B., and Wiik A. Comparison of viral antibodies in 2 groups of patients with fibromyalgia. J Rheumatol 28 (2001) 601-603
26. Dinerman H., and Steere A.C. Lyme disease associated with fibromyalgia. Ann Intern Med 117 (1992) 281-285
27. Buskila D., Gladman D.D., Langevitz P., Urowitz S., and Smythe H.A. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 17 (1990) 1202-1206
28. Simms R.W., Zerbini C.A., Ferrante N., Anthony J., Felson D.T., and Craven D.E. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team. Am J Med 92 (1992) 368-374
29. Buskila D., Shnaider A., Neumann L., Zilberman D., Hilzenrat N., and Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157 (1997) 2497-2500
30. Goulding C., O'Connell P., and Murray F.E. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 13 (2001) 507-511
31. Rivera J., De Diego A., Trinchet M., and García Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 36 (1997) 981-985
32. Dreyer L. Increased suicide, liver disease and cerebrovascular disease mortality in a cohort of Danish patients with fibromyalgia followed for 16 year [abstract] (2004), EULAR, Berlin